Supplemental Oxygen and Complications After Abdominal Surgery (The PROXI-trial)

This study has been completed.
Sponsor:
Collaborator:
The Danish Medical Research Council
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT00364741
First received: August 15, 2006
Last updated: October 15, 2009
Last verified: October 2009

August 15, 2006
October 15, 2009
October 2006
October 2008   (final data collection date for primary outcome measure)
Surgical wound infection [ Time Frame: 14 days after surgery ] [ Designated as safety issue: No ]
Surgical wound infection
Complete list of historical versions of study NCT00364741 on ClinicalTrials.gov Archive Site
Atelectasis, pneumonia, respiratory insufficiency, second operation, mortality, length of postoperative hospitalization, admission to intensive care unit. [ Time Frame: 30 days after surgery ] [ Designated as safety issue: Yes ]
Atelectasis, pneumonia, respiratory insufficiency, second operation, mortality, length of postoperative hospitalization, admission to intensive care unit.
Not Provided
Not Provided
 
Supplemental Oxygen and Complications After Abdominal Surgery (The PROXI-trial)
PeRioperative OXygen Fraction - Effect on Surgical Site Infection and Pulmonary Complications After Abdominal Surgery (The PROXI-trial)

Aim: To investigate the effect of high intra- and postoperative oxygen concentration (80%, as opposed to normally 30%) on surgical wound infection and pulmonary complications after abdominal surgery.

Background: Surgical wound infection is a common and serious complication. Tissue oxygen tension is often low after surgery and the resistance against infection depends on this factor through bacterial killing by neutrophils. Oxygen is a substrate in this reaction, and it is hypothesized that by increasing the arterial oxygen tension, the risk of surgical wound infection is reduced. Previous studies to test this hypothesis have shown entirely different results. Hence, the clinical decision between high and normal oxygen concentration is still controversial.

Primary hypothesis of study: Use of 80% oxygen decreases the incidence of surgical wound infection after abdominal surgery.

Secondary objectives: To investigate the effect 80% oxygen on pulmonary complications (atelectasis, pneumonia, respiratory insufficiency), second operation, mortality and length of postoperative hospitalization and admission to intensive care unit after abdominal surgery.

Not Provided
Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Laparotomy
Drug: Oxygen
During and 2 hours after surgery
  • Active Comparator: A
    Fraction of inspired oxygen (FiO2) = 0.30
    Intervention: Drug: Oxygen
  • Active Comparator: B
    FiO2 = 0.80
    Intervention: Drug: Oxygen

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1400
November 2008
October 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18 years or older.
  • Laparotomy, acute or elective. In case of gynaecological surgery only if malignancy is suspected (defined as risk of ovarian malignancy index >200 or a specimen with atypical or neoplastic cells).

Exclusion Criteria:

  • Other surgery within 30 days (except surgery in local anaesthesia).
  • Chemotherapy within 3 months.
  • Inability to give informed consent.
  • Inability to keep oxygen saturation above 90% without supplemental oxygen (measured preoperatively by pulse oximetry).
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00364741
2006-001710-32, GCP-2006-101, KF 02 306766
Yes
Lars S. Rasmussen, Department of Anaesthesia, HOC, Copenhagen University Hospital, Rigshospitalet
Rigshospitalet, Denmark
The Danish Medical Research Council
Study Chair: Lars S. Rasmussen, MD,DMSc,PHD Dept. of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Study Director: Jørn Wetterslev, MD, PHD Copenhagen Trial Unit, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Study Director: Lars N. Jørgensen, MD, DMSc Dept. of Surgery, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark
Principal Investigator: Christian S. Meyhoff, MD, PhD Dept. of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Rigshospitalet, Denmark
October 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP